Titre :

Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM).

Auteur(s) :

Hofer, S. [Auteur]
Keller, K. [Auteur]
Imbach, L. [Auteur]
Roelcke, U. [Auteur]
Hutter, G. [Auteur]
Thomas, H. [Auteur]
Hertler, C. [Auteur]
Le Rhun, Emilie [Auteur]
Universität Zürich [Zürich] = University of Zurich [UZH]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Vasella, F. [Auteur]
Cordier, D. [Auteur]
Neidert, M. [Auteur]
Hottinger, A. [Auteur]
Migliorini, D. [Auteur]
Pflugshaupt, T. [Auteur]
Eggenberger, N. [Auteur]
Baumert, B. [Auteur]
Läubli, H. [Auteur]
Gramatzki, D. [Auteur]
Reinert, M. [Auteur]
Pesce, G. [Auteur]
Schucht, P. [Auteur]
Frank, I. [Auteur]
Lehnick, D. [Auteur]
Weiss, T. [Auteur]
Hans-Georg, W. [Auteur]
Wolpert, F. [Auteur]
Roth, P. [Auteur]
Weller, M. [Auteur]

Titre de la revue :

Swiss Medical Weekly

Nom court de la revue :

Swiss Med Wkly

Numéro :

151

Pagination :

w20501

Date de publication :

2021-05-23

ISSN :

1424-3997

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

OBJECTIVE:The management of brain tumour patientswho would like to resume driving is complex, and needsmultidisciplinary input and a consensus among treatingphysicians. The Swiss Neuro-Oncology Society ...
Lire la suite >OBJECTIVE:The management of brain tumour patientswho would like to resume driving is complex, and needsmultidisciplinary input and a consensus among treatingphysicians. The Swiss Neuro-Oncology Society (Swiss-NOS) and the Swiss Society for Legal Medicine (SGRM)aim to provide guidance on how to assess “fitness-to-dri-ve” of glioblastoma patients and to harmonise the relevantprocedures in Switzerland.METHODS:At several meetings, Swiss neuro-oncologistsdiscussed common practices on how to advise patientswith a stable, i.e., non-progressive, glioblastoma, whowish to resume driving after the initial standard tumourtreatment. All participants of the SwissNOS meetings wereinvited twice to return a questionnaire (modified Delphiprocess) on specific tools/procedures they commonly useto assess “fitness-to-drive” of their patients. Answers wereanalysed to formulate a tentative consensus for a struc-tured and reasonable approach.RESULTS:Consensus on minimum requirements for a“fitness-to-drive”programme for glioblastoma patientscould be reached among Swiss neuro-oncologists. Therecommendations were based on existing guidelines andexpert opinions regarding patients with seizures, visualdisturbances, cognitive impairment or focal deficits forsafe driving. At this point in time, the Swiss neuro-oncol-ogists agreed on the following requirements for glioblas-toma patients after the initial standard therapy and withouta seizure for at least 12 months: (1) stable cranial mag-netic resonance imaging (MRI) according to ResponseAssessment in Neuro-Oncology (RANO) criteria, to berepeated every 3 months; (2) thorough medical history, in-cluding current or new medication, a comprehensive neu-rological examination at baseline (T0) and every 3 monthsthereafter, optionally an electrocencephalogram (EEG) atbaseline; (3) ophthalmological examination including visu-al acuity and intact visual fields; and (4) optional neuropsy-chological assessment with a focus on safe driving. Testresults have to be compatible with safe driving at any time-point. Patients should be informed about test results andoptionally sign a document.CONCLUSIONS:We propose regular thorough clinicalneurological examination and brain MRI, optional EEG,neuropsychological and visual assessments to confirm “fit-ness-to-drive” for glioblastoma patients after initial tumour-directed therapy. The proposed “fitness-to-drive” assess-ments for glioblastoma patients serves as the basis for a prospective Swiss Pilot Project GLIODRIVE (BASEC Pro-jectID 2020-00365) to test feasibility, adherence and safe-ty in a structured manner for patients who wish to resumedriving. Research will focus on confirming the usefulnessof the proposed tools in predicting “fitness-to-drive” andmatch results with events obtained from the road trafficregistry (Strassenverkehrsamt).Lire moins >

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Université de Lille
Inserm
CHU Lille

Collections :

• Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192

Date de dépôt :

2023-12-13T04:56:19Z
2024-01-31T14:27:50Z